Véronique Lecault
Fondatore presso ABCELLERA BIOLOGICS INC.
Patrimonio netto: 28 M $ in data 30/06/2024
Posizioni attive di Véronique Lecault
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ABCELLERA BIOLOGICS INC. | Direttore/Membro del Consiglio | 08/11/2012 | - |
| Direttore operativo | 08/11/2012 | - | |
| Fondatore | 08/11/2012 | - | |
Lineage Biosciences, Inc.
 Lineage Biosciences, Inc. Hospital/Nursing ManagementHealth Services Lineage Biosciences, Inc. engages in biotechnology services. The company was founded on May 30, 2014 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 01/01/2018 | - |
| AbCellera Australia Pty Ltd. | Direttore/Membro del Consiglio | 01/09/2019 | - |
Trianni, Inc.
 Trianni, Inc. BiotechnologyHealth Technology TRIANNI, Inc. operates as a biotech company. It specializes in antibody discovery technology using transgenic mice. Its Trianni Mouse platform enables the generation of fully-human monoclonal antibodies. The company was founded in 2010 and is headquartered in San Francisco, CA. | Direttore/Membro del Consiglio | 01/11/2020 | - |
Storia della carriera di Véronique Lecault
Formazione di Véronique Lecault
| University of British Columbia | Doctorate Degree |
| University of Ottawa | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Canada | 5 |
| Australia | 2 |
| Stati Uniti | 2 |
Posizioni
| Director/Board Member | 3 |
| Chief Operating Officer | 1 |
| Founder | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ABCELLERA BIOLOGICS INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Lineage Biosciences, Inc.
Lineage Biosciences, Inc. Hospital/Nursing ManagementHealth Services Lineage Biosciences, Inc. engages in biotechnology services. The company was founded on May 30, 2014 and is headquartered in Vancouver, Canada. | Health Services |
| AbCellera Australia Pty Ltd. | |
Trianni, Inc.
Trianni, Inc. BiotechnologyHealth Technology TRIANNI, Inc. operates as a biotech company. It specializes in antibody discovery technology using transgenic mice. Its Trianni Mouse platform enables the generation of fully-human monoclonal antibodies. The company was founded in 2010 and is headquartered in San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Véronique Lecault
- Esperienza
